Ubald Tamoufe

Hepatitis C Virus Genetic Diversity and Drug Mutational Analysis in Cameroon: 1992 to 2013

Judith Ndongo Torimiro, Laure Arlette Tchapda, Maurice Boda, Jude Saber Bimela, Dale Netski, Desire Takou, Donald Scot Burke, Ubald Tamoufe, Eitel Mpoudi-Ngole, Henry Namme Luma, Oudou Njoya, Wilfred Fon Mbacham, Nathan Wolfe & Stuart Ray · Microbiology Research Journal International · 2016

HCV infection is endemic in Cameroon. A Direct acting agent (DAAs), sofosbuvir that target the HCV non-structural 5B RNA-dependent RNA polymerase (NS5B RdRp) has recently been incorporated into the standard of care in Cameroon but no drug resistance study to this DAA has been rep...

Open access Research Article 10.9734/BMRJ/2016/28823

Low Prevalence and Risk Factors Related to HIV-1 Mother to Child Transmission under Option B+ Program at 3 Referral Military and Public Hospitals in Cameroon

Sabine Aimée Touangnou-Chamda, Maurice Boda, Arnaud Franck Elang, Donatien Serge Mbaga, Eric Simo, Sebastien Kenmoe, Justin Olivier Essindi, Chris André Mbongue Mikangue, Alexandra Emmanuelle Membangbi, Aicha Ngoutane, Carole Stéphanie Sake, Ubald Tamoufe, Jacky Njiki-Bikoi, Sara Honorine Riwom & Julius Mbekem Nwobegahay · Asian Journal of Research in Infectious Diseases · 2023

Immunodeficiency Virus type 1 (HIV-1) Mother-To-Child Transmission (MTCT) prevalence and its predictors. Following the limited success achieved with the previous MTCT prevention programs, the Cameroon’s public health ministry adopted in 2014 the Option B+ program that recommends...

Open access Research Article 10.9734/ajrid/2023/v14i2284